Clinical Trial Update: Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update assessing the long-term immunogenicity of Gardasil in HIV-infected adolescents and young adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Human Papillomavirus Infection

Drugs mentioned

• Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: University of Milan | Conditions: HPV, HIV | Phase 3 | Status: UNKNOWN